Richel, D J <br/><br/>
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2000 
 - 243-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies--blood<br/>Antigens, CD34--blood<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--blood<br/>CD4-CD8 Ratio<br/>Cell Survival<br/>Equipment Failure<br/>Female<br/>Graft Survival<br/>Humans<br/>Immunomagnetic Separation--instrumentation<br/>Leukapheresis--standards<br/>Lymphocyte Count<br/>Mice--immunology<br/>Middle Aged<br/>Survival Rate<br/>Time Factors<br/>Transplantation, Autologous--adverse effects